COR Therapeutics, Inc. to Release / Webcast Third Quarter Financial Results Tuesday, October 17, 2000.Business/Health Editors SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BW HealthWire)--Oct. 11, 2000 COR Therapeutics, Inc. (Nasdaq: CORR CORR Used on the consolidated tape to indicate a correction in a reported transaction : CORR.LAST.GY 50 WAS 51. ) today said that its third quarter 2000 financial results will be released on Tuesday, October 17, at 8:00 a.m. Eastern Daylight Time (EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT ). One-half hour later, at 8:30 a.m. EDT, as part of the Company's efforts to ensure full disclosure to all parties, COR Therapeutics will webcast a conference call live on the Company's internet site. The call will be led by Vaughn M. Kailian, President and Chief Executive Officer. To access the live call or the 7-day archive, please log onto http://www.corr.com. Please connect to the Company's website prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. Alternatively, the webcast may be accessed by logging on to http://www.vcall.com/NASApp/VCall/EventPage?ID=43401. COR Therapeutics, Inc. is dedicated to the discovery, development, and commercialization of novel pharmaceutical products for the treatment and prevention of severe cardiovascular diseases. COR has complementary research and development programs that seek to address critical needs in severe cardiovascular care, including unstable angina, acute myocardial infarction acute myocardial infarction ( |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion